IDT AustraliaASX:IDT Gross Margin % is 87.44% as of Dec. 2025, which is 9% above its 10-year median of 80.08. The stock has 6 warning signs investors should review. Among 938 Drug Manufacturers companies, IDT Australia ranks better than 92% on this metric.
IDT Australia Ltd gross margin has been in long-term decline. The average rate of decline per year is -5.3%.
The historical rank and industry rank for IDT Australia's Gross Margin % or its related term are showing as below:
ASX:IDT'
s Gross Margin % Range Over the Past 10 Years
Min: 68.16 Med: 80.08 Max: 92.53
Current: 80.17
During the past 13 years, the highestGross Margin % of IDT Australia was 92.53%. The lowest was 68.16%. And the median was 80.08%.
ASX:IDT's Gross Margin % is ranked better than 92% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs ASX:IDT: 80.17
IDT Australia had a gross margin of 87.44% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for IDT Australia was -5.30% per year.
IDT Australia (ASX:IDT) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
IDT Australia had a gross margin of 87.44% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
IDT Australia Gross Margin % Related Terms
IDT Australia Gross Margin % Historical Data
* Premium members only.
The historical data trend for IDT Australia's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDT Australia Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IDT Australia's Gross Margin % distribution charts can be found below:
* The bar in red indicates where IDT Australia's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
IDT Australia (ASX:IDT) has a Gross Margin % of 87.44% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on IDT Australia and its competitors. This is near median its historical median of 80.08. Over the past decade, IDT Australia's Gross Margin % has ranged from 68.16 to 92.53. According to the industry distribution chart, IDT Australia ranks #75 out of 938 companies in the Drug Manufacturers industry, placing it in the top 8%.
Is IDT Australia's Gross Margin % too high?
IDT Australia's current Gross Margin % of 87.44% is near median its 10-year median of 80.08. Over the past 10 years, this metric has ranged from a low of 68.16 to a high of 92.53. The Drug Manufacturers industry median Gross Margin % is 48.44. IDT Australia's value of 87.44% is 80.5% above this industry median. Based on the distribution chart, IDT Australia ranks #75 out of 938 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does IDT Australia's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IDT Australia ranks #75 out of 938 companies for Gross Margin %. This places IDT Australia in the top 8% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.44. IDT Australia's value of 87.44% is 80.5% above this benchmark. Historically, IDT Australia's own Gross Margin % has ranged from 68.16 to 92.53 over the past decade. While the company's 10-year median is 80.08 vs. the industry median of 48.44, IDT Australia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDT Australia's current Gross Margin % of 87.44% is 80.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on IDT Australia and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDT Australia's current Gross Margin % is 87.44%, which is near median its own 10-year median of 80.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
Based on GuruFocus' analysis, IDT Australia (ASX:IDT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.17, compared to a current price of A$0.03 — trading 80.6% below its estimated fair value. The current Gross Margin % is 87.44%, which is near median its 10-year median of 80.08 and 80.5% above the Drug Manufacturers industry median of 48.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For IDT Australia (ASX:IDT), the current Gross Margin % is 87.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IDT has been successfully added to your 